← Back to Search

Remote Patient Monitoring for Patient Activation

N/A
Waitlist Available
Led By Michelle Lampman, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will evaluate the effectiveness of nurse-based care coordination and nurse-based remote patient monitoring on hospital readmissions among primary care patients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Readmission

Trial Design

3Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
The usual care group will not receive additional supportive care following discharge from a recent hospitalization beyond what is typically offered through their primary care team.
Group II: Remote Patient MonitoringActive Control1 Intervention
This group will receive remote patient monitoring following discharge from a recent hospitalization.
Group III: Adult Medical Care CoordinationActive Control1 Intervention
This group will receive adult medical care coordination following discharge from a recent hospitalization.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,200 Previous Clinical Trials
3,758,948 Total Patients Enrolled
Michelle Lampman, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrolment to this clinical trial still open?

"Reports on clinicaltrials.gov indicate that this particular medical trial, initially posted in January 2020 and recently updated in July 2022, is not currently enrolling patients. However, there are 5 other studies actively seeking participants at the present moment."

Answered by AI
~371 spots leftby Apr 2025